Biomarkers Definitions Working Group 2001 Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 69: 89-95 Bland J M, Altman D G 2000 Statistical notes. The odds ratio. British Medical Journal 320:1468 Chalmers 11995 What do I want from health research and researchers when I am a patient? British Medical Journal 310:1315-1318 Chatellier G et al 1996 The numbers needed to treat: a clinically useful nomogram in its proper context. British Medical Journal 312: 426-429 Doll R 1998 Controlled trials: the 1948 watershed. British Medical Journal 317:1217 (and following articles).
Egger M et al 1997 Meta-analysis. Principles and practice. British Medical Journal 315:1533-1537 (See also other articles in the series entitled 'Metaanalysis'.)
Emanuel E J, Miller F G 2001 The ethics of placebo-controlled trials — a middle ground. New England Journal of Medicine 345:915-919 Greenhalgh T 1997 Papers that report drug trials. British Medical Journal 315: 480-483 (See also other articles in the series entitled 'How to read a paper'.)
Hrobjartsson A, Gotzsche P C 2001 Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine 344:1594-1602 Kaptchuk T J 1998 Powerful placebo: the dark side of the randomised controlled trial. Lancet 351: 1722-1725
Levy G 1992 Publication bias: Its implications for clinical pharmacology. Clinical Pharmacology and Therapeutics 52:115-119 Lewis J et al 2002 Placebo-control led trials and the Declaration of Helsinki. Lancet 359:1337-1340 Pogue J, Yusuf S 1998 Overcoming the limitations of current meta-analysis of randomized controlled trials. Lancet 351:47-52 Silverman W A, Altman D G 1996 Patients'
preferences and randomized trials. Lancet 347: 171-174
Sibbald B, Roland M 1998 Why are randomised controlled trials important? British Medical Journal 316: 201 (See also subsequent articles in this series entitled 'Understanding controlled trials'.) Urquhart J 2001 Demonstrating effectiveness in a postplacebo era. Clinical Pharmacology and Therapeutics 70:115-120 Waller P C, Jackson P R, Tucker G T, Ramsay L E 1994 Clinical pharmacology with confidence [intervals]. British Journal of Clinical Pharmacology 37: 309
39 'Quick, let us prescribe this new drug while it remains effective'. Richard Asher.
40 By courtesy of Dr Robert H Williams and the Editor of The Journal of the American Medical Association.
This page intentionally left blank
Was this article helpful?
Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.